UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials

The Lancet (British edition), 2018-08, Vol.392 (10148), p.650-661

2018

Volltextzugriff (PDF)

Ethnicity‐based differences in the incident risk of allergic diseases and autoimmune disorders: A UK‐based retrospective cohort study of 4.4 million participants

Clinical and experimental allergy, 2021-01, Vol.51 (1), p.144-147

2021

Volltextzugriff (PDF)

Long‐term efficacy and safety of ixekizumab in Japanese patients with erythrodermic or generalized pustular psoriasis: subgroup analyses of an open‐label, phase 3 study (UNCOVER‐J)

Journal of the European Academy of Dermatology and Venereology, 2019-02, Vol.33 (2), p.325-332

2019

Volltextzugriff (PDF)

The epidemiology of atopic dermatitis and psoriasis in the indigenous people of Brazil

Journal of the European Academy of Dermatology and Venereology, 2024-10, Vol.38 (10), p.e898-e901

2024

Volltextzugriff (PDF)

Racial/ethnic differences in biologic treatment patterns among patients with psoriasis: A prospective analysis of patients in the CorEvitas Psoriasis Registry

Journal of the American Academy of Dermatology, 2024-10, Vol.91 (4), p.717-719

2024

Volltextzugriff (PDF)

Human leucocyte antigen-Cw6 as a predictor for clinical response to ustekinumab, an interleukin-12/23 blocker, in Chinese patients with psoriasis: a retrospective analysis

British journal of dermatology (1951), 2014-11, Vol.171 (5), p.1181-1188

2014

Volltextzugriff (PDF)

Racial differences in access to psoriasis biologics

The Journal of dermatological treatment, 2024-12, Vol.35 (1), p.2360572-2360572

2024

Volltextzugriff (PDF)

Mutation Analysis of the IL36RN Gene in 14 Japanese Patients with Generalized Pustular Psoriasis

Human mutation, 2013-01, Vol.34 (1), p.176-183

2013

Volltextzugriff (PDF)

Population Pharmacokinetics of the Interleukin-23 Inhibitor Risankizumab in Subjects with Psoriasis and Crohn’s Disease: Analyses of Phase I and II Trials

Clinical pharmacokinetics, 2019-03, Vol.58 (3), p.375-387

2019

Volltextzugriff (PDF)

CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts

British journal of dermatology (1951), 2016-02, Vol.174 (2), p.330-337

2016

Volltextzugriff (PDF)

Frequency of Skin Biopsies for Psoriasis by Race and Ethnicity

JAMA dermatology (Chicago, Ill.), 2024-09, Vol.160 (9), p.1003

2024

Volltextzugriff (PDF)

Trends in incidence of adult-onset psoriasis over three decades: A population-based study

Journal of the American Academy of Dermatology, 2009-03, Vol.60 (3), p.394-401

2009

Volltextzugriff (PDF)

Epidemiology of psoriatic disease and current treatment patterns from 2003 to 2013: A nationwide, population-based observational study in Taiwan

Journal of dermatological science, 2016-12, Vol.84 (3), p.340-345

2016

Volltextzugriff (PDF)

Prevalence of psoriasis in Brazil – a geographical survey

International journal of dermatology, 2017-08, Vol.56 (8), p.e167-e168

2017

Volltextzugriff (PDF)

Differential patient travel distance and time to psoriasis clinical trial sites

Archives of dermatological research, 2023-10, Vol.315 (8), p.2359-2363

2023

Volltextzugriff (PDF)

Ethnicity affects the presenting severity of psoriasis

Journal of the American Academy of Dermatology, 2017-07, Vol.77 (1), p.180-182

2017

Volltextzugriff (PDF)

Integrative methylome and transcriptome analysis to dissect key biological pathways for psoriasis in Chinese Han population

Journal of dermatological science, 2018-09, Vol.91 (3), p.285-291

2018

Volltextzugriff (PDF)

Psoriatic Disease in the US Latino Population: A Comprehensive Review

American journal of clinical dermatology, 2020-04, Vol.21 (2), p.265-274

2020

Volltextzugriff (PDF)

Psoriasis and psoriatic arthritis in African-American patients—the need to measure disease burden

Clinical rheumatology, 2015-10, Vol.34 (10), p.1753-1759

2015

Volltextzugriff (PDF)

Efficacy and Safety of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis and Skin of Color: Results from the Pooled AMAGINE-2/-3 Randomized Trials

American journal of clinical dermatology, 2019-04, Vol.20 (2), p.267-276

2019

Volltextzugriff (PDF)

Leptin induces secretion of pro-inflammatory cytokines by human keratinocytes in vitro - a possible reason for increased severity of psoriasis in patients with a high body mass index

Experimental dermatology, 2013-06, Vol.22 (6), p.406-410

2013

Volltextzugriff (PDF)

HLA polymorphism among Chinese patients with chronic plaque psoriasis: subgroup analysis

British journal of dermatology (1951), 2012-02, Vol.166 (2), p.288-297

2012

Volltextzugriff (PDF)

Uveitis in Chinese Patients with Psoriasis

Ocular immunology and inflammation, 2017-11, Vol.25 (6), p.855-865

2017

Volltextzugriff (PDF)

The prevalence of psoriasis in African Americans: Results from a population-based study

Journal of the American Academy of Dermatology, 2005, Vol.52 (1), p.23-26

2005

Volltextzugriff (PDF)

Clinical features of psoriatic uveitis in Japanese patients

Graefe's archive for clinical and experimental ophthalmology, 2015-07, Vol.253 (7), p.1175-1180

2015

Volltextzugriff (PDF)

1 – 25 von 141

Suche als RSS-Feed

Aktive Filter

KollektionEZB Electronic Journals Library

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(129)
Mit Volltextzugriff
(113)

Publikationsform

Artikel
(140)
magazinearticle
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials

Ethnicity‐based differences in the incident risk of allergic diseases and autoimmune disorders: A UK‐based retrospective cohort study of 4.4 million participants

Long‐term efficacy and safety of ixekizumab in Japanese patients with erythrodermic or generalized pustular psoriasis: subgroup analyses of an open‐label, phase 3 study (UNCOVER‐J)

The epidemiology of atopic dermatitis and psoriasis in the indigenous people of Brazil

Racial/ethnic differences in biologic treatment patterns among patients with psoriasis: A prospective analysis of patients in the CorEvitas Psoriasis Registry

Human leucocyte antigen-Cw6 as a predictor for clinical response to ustekinumab, an interleukin-12/23 blocker, in Chinese patients with psoriasis: a retrospective analysis

Racial differences in access to psoriasis biologics

Mutation Analysis of the IL36RN Gene in 14 Japanese Patients with Generalized Pustular Psoriasis

Population Pharmacokinetics of the Interleukin-23 Inhibitor Risankizumab in Subjects with Psoriasis and Crohn’s Disease: Analyses of Phase I and II Trials

CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts

Frequency of Skin Biopsies for Psoriasis by Race and Ethnicity

Trends in incidence of adult-onset psoriasis over three decades: A population-based study

Epidemiology of psoriatic disease and current treatment patterns from 2003 to 2013: A nationwide, population-based observational study in Taiwan

Prevalence of psoriasis in Brazil – a geographical survey

Differential patient travel distance and time to psoriasis clinical trial sites

Ethnicity affects the presenting severity of psoriasis

Integrative methylome and transcriptome analysis to dissect key biological pathways for psoriasis in Chinese Han population

Psoriatic Disease in the US Latino Population: A Comprehensive Review

Psoriasis and psoriatic arthritis in African-American patients—the need to measure disease burden

Efficacy and Safety of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis and Skin of Color: Results from the Pooled AMAGINE-2/-3 Randomized Trials

Leptin induces secretion of pro-inflammatory cytokines by human keratinocytes in vitro - a possible reason for increased severity of psoriasis in patients with a high body mass index

HLA polymorphism among Chinese patients with chronic plaque psoriasis: subgroup analysis

Uveitis in Chinese Patients with Psoriasis

The prevalence of psoriasis in African Americans: Results from a population-based study

Clinical features of psoriatic uveitis in Japanese patients

Aktive Filter

Suchergebnisse filtern